Becton Dickinson & Co (BDX)
227.11
-12.95
(-5.39%)
USD |
NYSE |
Nov 07, 16:00
227.40
+0.29
(+0.13%)
After-Hours: 20:00
Becton Dickinson Revenue (TTM): 19.83B for June 30, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| June 30, 2024 | 19.83B |
| March 31, 2024 | 19.72B |
| December 31, 2023 | 19.49B |
| September 30, 2023 | 19.37B |
| June 30, 2023 | 19.05B |
| March 31, 2023 | 18.81B |
| December 31, 2022 | 18.74B |
| September 30, 2022 | 18.87B |
| June 30, 2022 | 18.96B |
| March 31, 2022 | 18.92B |
| December 31, 2021 | 19.08B |
| September 30, 2021 | 19.68B |
| June 30, 2021 | 18.57B |
| March 31, 2021 | 17.82B |
| December 31, 2020 | 17.16B |
| September 30, 2020 | 16.07B |
| June 30, 2020 | 16.92B |
| March 31, 2020 | 17.41B |
| December 31, 2019 | 17.35B |
| September 30, 2019 | 17.29B |
| June 30, 2019 | 17.11B |
| March 31, 2019 | 17.04B |
| December 31, 2018 | 17.06B |
| September 30, 2018 | 15.98B |
| June 30, 2018 | 14.75B |
| Date | Value |
|---|---|
| March 31, 2018 | 13.50B |
| December 31, 2017 | 12.25B |
| September 30, 2017 | 12.09B |
| June 30, 2017 | 12.16B |
| March 31, 2017 | 12.32B |
| December 31, 2016 | 12.42B |
| September 30, 2016 | 12.48B |
| June 30, 2016 | 12.31B |
| March 31, 2016 | 12.23B |
| December 31, 2015 | 11.22B |
| September 30, 2015 | 10.28B |
| June 30, 2015 | 9.424B |
| March 31, 2015 | 8.461B |
| December 31, 2014 | 8.482B |
| September 30, 2014 | 8.446B |
| June 30, 2014 | 8.345B |
| March 31, 2014 | 8.241B |
| December 31, 2013 | 8.169B |
| September 30, 2013 | 8.054B |
| June 30, 2013 | 7.920B |
| March 31, 2013 | 7.847B |
| December 31, 2012 | 7.776B |
| September 30, 2012 | 7.708B |
| June 30, 2012 | 7.729B |
| March 31, 2012 | 7.701B |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
16.07B
Minimum
Sep 2020
19.83B
Maximum
Jun 2024
18.52B
Average
18.87B
Median
Sep 2022
Revenue (TTM) Benchmarks
| Boston Scientific Corp | 15.91B |
| Moderna Inc | 4.988B |
| Abbott Laboratories | 41.22B |
| Eli Lilly and Co | 40.86B |
| Merit Medical Systems Inc | 1.326B |